Comparative effectiveness of pharmacologic agents for heart failure prevention in post-myocardial infarction patients: A comprehensive Bayesian network meta-analysis

4 April 2025 (15:00 - 15:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Valeria Chiara Lanari

Milan (Italy)

5 More presentations in this session

Presentation thumbnail

Eccentric overload training in patients with heart failure: assessing delayed onset muscle soreness to determine feasibility

Mr S. Naessens (Edegem, BE)

Abstract Slides

Presentation thumbnail

Heart failure and early cardiac rehabilitation: pilot experience and definition of the patient journey

Doctor F. Di Salvo (Milan, IT)

Abstract Slides

Presentation thumbnail

Growth hormone replacement therapy in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial

Associate Professor A. Marra (Naples, IT)

Abstract Slides

Presentation thumbnail

The correlation between the modifiable risk factors in hospital readmissions and critical phase in heart failure patients

Doctor A. Lacraru (Bucharest, RO)

Abstract Slides

Presentation thumbnail

Effects of an in-hospital physical activity motivational programme in chronic heart failure or chronic obstructive pulmonary disease patients undergoing rehabilitation: a randomized controlled trial

Doctor C. Simonelli (Lumezzane, IT)

Abstract Slides

Access the full session

Session thumbnail

Pharmacological and non-pharmacological interventions in heart failure

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 15:00 CET

You may be interested in

Webinar

Personalised secondary prevention post-ACS: the role of biomarkers

Webinar

Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum

Congress Presentation

Prevention should always follow intervention

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources